Chlorpheniramine 4mg Injection

Introduction

Chlorpheniramine is a prescription medication that contains Chlorpheniramine Maleate as its active ingredient. It is available under the brand name Chlorpheniramine. This medication is primarily used to relieve symptoms associated with various allergic conditions.

Uses

Chlorpheniramine is prescribed for the treatment of allergic conditions, including allergic rhinitis (hay fever), allergic conjunctivitis (eye allergy), and allergic skin reactions. It can also be used to manage symptoms caused by insect bites or stings.

Dosage and Administration

Chlorpheniramine is administered by a healthcare professional, usually through an intramuscular or intravenous injection. The dosage will vary depending on the specific condition being treated and the patient’s age and weight. Follow the instructions provided by your healthcare provider for the correct dosage and administration method.

Mechanism of Action

Chlorpheniramine Maleate, the active ingredient in Chlorpheniramine, belongs to a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that is responsible for allergic symptoms. By blocking histamine, Chlorpheniramine helps relieve symptoms such as sneezing, itching, watery eyes, and runny nose.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and blurred vision. These side effects are usually mild and go away on their own. However, if they persist or become severe, consult your healthcare provider.

Serious side effects of Chlorpheniramine are rare but may include difficulty urinating, rapid heartbeat, confusion, and seizures. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Chlorpheniramine may interact with certain medications, including sedatives, tranquilizers, and other antihistamines. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid potential drug interactions.

Precautions

Before using Chlorpheniramine, inform your healthcare provider if you have any known allergies, especially to antihistamines or any other medications. Additionally, let your healthcare provider know about any other medical conditions you have, such as glaucoma, asthma, or urinary retention, as Chlorpheniramine may not be suitable for you.

Chlorpheniramine may cause drowsiness and impair your ability to drive or operate machinery. Avoid activities that require alertness until you know how this medication affects you.

Storage

Patient Tips

• Follow the dosage instructions provided by your healthcare provider and do not exceed the recommended dose.
• If you miss a dose, contact your healthcare provider for guidance on when to take the next dose.
• Inform your healthcare provider about any other medications you are taking, including over-the-counter drugs and herbal supplements.
• If you experience any unusual or persistent side effects, contact your healthcare provider.
• Avoid consuming alcohol while using Chlorpheniramine, as it may increase the risk of side effects.
• If you are pregnant or breastfeeding, consult your healthcare provider before using this medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Chlorphenamine: drowsy (sedating) antihistamine (NHS UK) [Accessed 29 Jun. 2024] (online) Available at:
• Chlorpheniramine (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• chlorpheniramine maleate (OTC) [Accessed 11 Jun. 2024] (online) Available at:
• Codeine (MedlinePlus) [Accessed 21 Jun. 2024] (online) Available at:
• Kumar M, Upadhayay P, Shankar R, Joshi M, Bhatt S, Malik A. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Drug Deliv Transl Res. 2019 Dec;9(6):1017-1026. doi: 10.1007/s13346-019-00639-w. [Accessed 13 Jun. 2024] Available at: